Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE)
- Conditions
- Chronic Renal InsufficiencyChronic Kidney FailureAged
- Registration Number
- NCT01225458
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
The trial is a multicenter, prospective, randomized, open study. A total of 500 elderly patients aged over 75 years with renal insufficiency stage 5 will be included in the study after signed informed consent. Patients will be randomized 1/1 in two arms : 250 patients in the "exclusive nephrology follow-up" arm will continue their usual follow-up; 250 patients in the "geriatric follow-up" arm will have both their usual nephrology follow-up and a geriatric follow-up.
The aim of the study is to determine if a systematized gerontologist evaluation delay the occurrence of a composite primary endpoint : death, dementia, depression and severe dependency. The hypothesis is that the functional and vital prognosis of a patient with renal insufficiency depends not only on common and classical factors but also on cognitive and psychological functions and dependence, particularly in elderly patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 48
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method death every 6 month for 3 years since inclusion occurrence of a severe dementia (MMS < 10) every 6 month for 3 years since inclusion major depression detected by GDS-15 > 10/15 and confirmed by DSM-IV criteria every 6 month for 3 years since inclusion severe dependency (ADL < 3/6) every 6 month for 3 years since inclusion
- Secondary Outcome Measures
Name Time Method cognitive, psychic and autonomy scores every 6 month for 3 years since inclusion bone fracture every 6 month for 3 years since inclusion nutritional parameters every 6 month for 3 years since inclusion dialysis parameters every 6 month for 3 years since inclusion cardiovascular morbidity and mortality every 6 month for 3 years since inclusion biological follow-up of chronic kidney disease including haemoglobin level every 6 month for 3 years since inclusion
Trial Locations
- Locations (1)
CHU de Nice
🇫🇷Nice, France
CHU de Nice🇫🇷Nice, France